Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 5 Deoxy D Ribose. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of 1,2,3-tri-O-acetyl-5-deoxy-beta-D-ribose via inosine route. Offers high purity, cost reduction, and reliable supply for pharmaceutical manufacturing.
Patent CN102260298A reveals a high-yield synthesis route for 1,2,3-O-triacetyl-5-deoxy-beta-D-ribose, offering cost reduction in API manufacturing and reliable supply chain solutions.
Advanced three-step synthetic route for Sofosbuvir intermediate reduces impurities and enhances supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN112125939B reveals a novel acylation and recrystallization route for 5-deoxy-D-ribose, offering superior purity and scalable production for nucleoside drug synthesis.
Novel patent CN104650160A offers high yield 1,2,3-O-triacetyl-5-deoxy-D-ribose synthesis. Ensures supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102260298B details a high-yield synthesis of key capecitabine intermediates using inosine, offering significant cost reduction and supply chain reliability for manufacturers.
Novel boronic acid protection method for high-purity ribose intermediate. Reduces steps and safety risks for scalable pharmaceutical manufacturing supply chains.